Loading...
Archive2020-10-16T12:22:18-07:00

Renew Biopharma Inc CEO on Developing Biosynthetic Cannabinoid Therapeutics for TBI

April 25th, 2019|

Renew Biopharma Inc is a research company developing proprietary therapeutics to treat neurodegenerative diseases, traumatic brain injuries (TBI), and for pain management. CEO Mike Mendez provides an introduction to the company and explains its interest in developing treatments using biosynthetic cannabinoids.

NBC Bay Area: Concussion Treatment: Cannabis Ingredient May Be Key, New Research Shows

May 2nd, 2018|

NBC Bay Area 2 Part Series: Perhaps the biggest threat to contact sports, particularly football, is concussions. They’re ending careers early and leaving countless players with permanent brain damage. But new research in California suggests there could be a cure on the horizon.

Next Gen Cannabinoids for Clinical Neurology

Contact Us

General Inquiries: info@renewbiopharma.com

Press Inquiries: press@renewbiopharma.com

Contact Us